Journal
CURRENT OPINION IN CHEMICAL BIOLOGY
Volume 14, Issue 2, Pages 262-268Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.cbpa.2009.12.012
Keywords
-
Categories
Funding
- NIH [U54-CA119343]
- NSF [DMR-0906662]
- Division Of Materials Research
- Direct For Mathematical & Physical Scien [0906662] Funding Source: National Science Foundation
Ask authors/readers for more resources
Nanoparticle-based therapeutics have received increasing attention, as these systems can alleviate many drawbacks of conventional therapy. Metal-organic frameworks (MOFs), a new class of hybrid materials composed of metal ions and organic bridging ligands, have emerged as a promising platform for drug delivery, owing to their high drug loadings, biodegradability, and versatile functionality. The bulk MOF materials can absorb and release large amounts of therapeutics including ibuprofen, procainamide, and nitric oxide. Scale-down of MOFs to the nanoregime yields nanoscale metal-organic frameworks (NMOFs) that are more applicable as delivery vehicles, such as selective delivery of cisplatin prodrugs. Although progress has been made in utilizing NMOFs for drug delivery, many improvements must occur before they can become viable nanotherapeutics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available